n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime has been researched along with Diabetic Nephropathies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, JH; Han, HJ; Kim, DI; Lim, SK; Park, MJ; Park, SH; Yoon, KC | 1 |
1 other study(ies) available for n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime and Diabetic Nephropathies
Article | Year |
---|---|
High glucose-induced O-GlcNAcylated carbohydrate response element-binding protein (ChREBP) mediates mesangial cell lipogenesis and fibrosis: the possible role in the development of diabetic nephropathy.
Topics: Acetylglucosamine; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; beta-N-Acetylhexosaminidases; Cholesterol; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Gene Expression Regulation, Enzymologic; Glucose; HEK293 Cells; Humans; Lipogenesis; Mesangial Cells; Oximes; Phenylcarbamates; Rats; Sweetening Agents; Triglycerides | 2014 |